The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
RTS,S/AS01 vaccine (Mosquirix™): an overview
Open accessAbstract
exacts the highest toll in terms of human morbidity and mortality, and therefore represents a major public health threat in endemic areas. Recent advances in control efforts have reduced malaria incidence and prevalence, including rapid diagnostic testing, highly effective artemisinin combination therapy, use of insecticide-treated bednets, and indoor residual spraying. But, reductions in numbers of cases have stalled over the last few years, and incidence may have increased. As this concerning trend calls for new tools to combat the disease, the RTS,S vaccine has arrived just in time. The vaccine was created in 1987 and began pilot implementation in endemic countries in 2019. This first-generation malaria vaccine demonstrates modest efficacy against malaria illness and holds promise as a public health tool, especially for children in high-transmission areas where mortality is high.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stoute, J. A., Slaoui, M., Heppner, D. G., Momin, P., Kester, K. E., Desmons, P., Wellde, B. T., Garçon, N., Krzych, U., Marchand, M., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199701093360202 · Cited by 870
Ayanful-Torgby, R., Quashie, N. B., Boampong, J. N., Williamson, K. C., & Amoah, L. E. (2018) · PLOS ONE · doi:10.1371/journal.pone.0199172 · Cited by 52
Cited by
Malaria diagnostic methods with the elimination goal in view
Oyegoke, O. O., Maharaj, L., Akoniyon, O. P., Kwoji, I., Roux, A. T., Adewumi, T. S., Maharaj, R., Oyebola, B. T., Adeleke, M. A., & Okpeku, M. (2022) · Parasitology Research · doi:10.1007/s00436-022-07512-9 · Cited by 82
Current landscape of innovative drug development and regulatory support in China
Tan, R., Hua, H., Zhou, S., Yang, Z., Yang, C., Huang, G., Zeng, J., & Zhao, J. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02267-y · Cited by 51
Acceptance, availability, and feasibility of RTS, S/AS01 malaria vaccine: A review
Mumtaz, H., Nadeem, A., Bilal, W., Ansar, F., Saleem, S., Khan, Q. A., Tango, T., Farkouh, C., Belay, N. F., Verma, R., et al. (2023) · Immunity, Inflammation and Disease · doi:10.1002/iid3.899 · Cited by 42
Malaria in pregnancy: adverse pregnancy outcomes and the future of prevention
Berhe, A. D., Doritchamou, J. Y. A., & Duffy, P. E. (2023) · Frontiers in Tropical Diseases · doi:10.3389/fitd.2023.1229735 · Cited by 30
Garzon, T., Ortega-Tirado, D., Lopez-Romero, G., Alday, E., Robles-Zepeda, R. E., Garibay-Escobar, A., & Velazquez, C. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.769446 · Cited by 14
Metadata
- Authors
- Laurens, M. B.
- Venue
- Human Vaccines & Immunotherapeutics
- Publisher
- Informa UK Limited
- Published
- 2019-10-22
- Volume
- 16
- Issue
- 3
- Pages
- 480-489
- ISSN
- 2164-5515 (ISSN-L)
- 2164-554X
- OpenAlex
- W2976620503
- Cited by
- 491
- References
- 2
- FWCI
- 33.07
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: RTS,S/AS01 vaccine (Mosquirix™): an overview. https://app.cochat.ai/papers/10.1080/21645515.2019.1669415
- The paper
- Laurens, M. B. (2020). RTS,S/AS01 vaccine (Mosquirix™): an overview. Human Vaccines & Immunotherapeutics. https://doi.org/10.1080/21645515.2019.1669415
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
